Difficulties in excluding Cushing syndrome in obese subjects

Endocrinologist

Volumn 16, Issue 1, 2006, Pages 15-19

  Tran, Huy A ^a   Petrovksy, Nikolai ^b  

^a JOHN HUNTER HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Cushing syndrome; Dexamethasone; Obese; Suppression test

Indexed keywords

DEXAMETHASONE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMORBIDITY; CREATININE CLEARANCE; CUSHING SYNDROME; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; HYDROCORTISONE URINE LEVEL; INCIDENCE; MALE; OBESITY; PROVOCATION TEST; SCREENING TEST;

EID: 33746102746     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000191747.48192.fb     Document Type: Article

References (20)

1. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
2. Stein CJ, Colditz GA. The epidemic of obesity. J Clin Endocrinol Metab. 2004;89:2522-2525.
3. Cameron AJ, Welborn TA, Zimmet PZ, et al. Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust. 2003;178:427-432.
4. Arnaldi GA, Atkinson AB, Bertagna X, et al. Diagnosis and Complication of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88:5593-5602.
5. Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing's syndrome. Ann Intern Med. 2003;138:980-991.
6. Yanovski AJ, Cutler BG Jr, Chrousos PG, et al. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA. 1993;269:2232-2238.
7. Newcombe RG, Altman DG. Proportions and their differences. In: Altman DG, Machin D, Bryant NT, et al., eds. Statistics With Confidence, 2nd ed. British Medical Journal Books; 2000:45-56.
8. Andrew R, Phillips WID, Walker RB. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab. 1998;83:1806-1809.
9. Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin North Am. 2002;31:173-189.
10. Wood PJ, Barth JH, Freedman DB, et al. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome - recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem. 1997;34:222-229.
11. Crapo L. Cushing's syndrome: a review of diagnostic tests. Metabolism. 1979;28:955-977.
12. Newell-Price J, Trainer P, Besser M, et al. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev. 1998;19:647-672.
13. Boscaro M, Barzon L, Sonino N. The diagnosis of Cushing's syndrome: atypical presentations and laboratory shortcomings. Arch Intern Med. 2000;160:3045-3053.
14. Ramirez G, Gomez-Sanchez C, Meikle WA, et al. Evaluation of the hypothalamic hypophyseal adrenal axis in patients receiving long-term hemodialysis. Arch Intern Med. 1982;142:1448-1452.
15. Raff H, Findling JW. Diagnosis and differential diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am. 2001;30:729-747.
16. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-147.
17. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am. 2000;29:43-56.
18. Ness-Abramof R, Nabriski D, Apovian CM, et al. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese. Obes Res. 2002;10:1217-1221.
19. Findling WJ, Hershel R, Aron DC. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. J Clin Endocrinol Metab. 2004;89:1222-1226.
20. Ross NS. Epidemiology of Cushing's syndrome and subclinical disease. Endocrinol Metab Clin North Am. 1994;23:539-546.